About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Dietary strategies aimed solely at lowering saturated fat intake may be less effective in reducing cardiovascular disease (CVD) than recommendations for a plant-centered diet.
Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.
Statin prescribing for at-risk individuals decreases among primary care providers as the day progresses, particularly in the afternoon compared with the morning.
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.
